As TAAR1 might become a new target for schizophrenia since the discovery of D2 dopamine receptor blocking the action of antipsychotics more than 50 years ago, TAAR5 may emerge as a novel target for mood disorders. The gene discussed is DRD2; the disease is schizophrenia.